Skip to main content

Animations

MJFF Publications

6001 - 6010 of 8654 Results
Title
Year
  • Year
  • 2018
  • 2024
  • 2011
  • 2016
  • 2019
  • 2024
  • 2014
  • 2024
  • 2024
  • 2019
  • Summary Details
    OPEN
    Title: Minimal Clinically Important Difference for UPDRS‐III in Daily Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12632
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14208
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024
    Citation Count: 169
  • Summary Details
    OPEN
    Title: Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.6b00217
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-54063-8
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) Cells
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom14060647
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents
    Journal Name: Journal of Comparative Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/cne.23612
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A person-centered approach to characterizing longitudinal ambulatory impairment in Parkinson's disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-62179-9
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Orthogonal analysis of mitochondrial function in Parkinson’s disease patients
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06617-6
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9
    Citation Count: 123
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.